Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Breast, The Value of Protons, Cardiotoxicity and RadComp

14/09/2022
/ Webinar
/
Toxicity

During ISOP 2022, Shannon McDonald presented "Breast, The Value of Protons, Cardiotoxicity and RadComp".

Watch the webinar above.

Breast and chest wall treatment with pencil beam scanning at the proton therapy center in Prague

02/02/2018
/ Event
/
Proton therapy center
Pencil Beam Scanning - PBS

The Proton Therapy Centre in Prague (PTC) is a leading global health care facility and one of the most advanced proton therapy providers in Europe. The centre...

Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.

15/11/2022
/ Publications

This study reports 3-year outcomes of the Proton Collaborative Group phase II trial (PCG BRE007-12) that recruited women ≥ 50 years with node-negative, estrogen...

Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone.

16/01/2023
/ Publications

This study reported outcomes of 19 patients with locoregional recurrent breast cancer treated with PT. All patients had mastectomy without prior RT. Seventeen...

Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery.

16/01/2023
/ Publications

This study reported early toxicity and cosmetic outcomes of 21 patients treated with breast-conserving surgery and adjuvant PBT. Grade 2 and 3 dermatitis...

CNS & Leptomeningeal Disease

24/02/2023
/ Webinar

Minesh Mehta covers three indications that are very promising for proton therapy: leptomeningeal disease, low-grade glioma, and glioblastoma. Watch the talk's...

Proton Therapy for Locally Advanced Breast Cancer with a Focus on Cardiac Benefits

24/02/2023
/ Webinar

Shannon MacDonald covers one of proton therapy's growing indications: breast cancer. In her talk, she focuses on locally advanced breast cancer and cardiac...

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.

23/11/2023
/ Publications

Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy.

01/03/2024
/ Publications

This study compared acute toxicities and reconstructive complications in patients treated with proton-based (n = 11)and photon-based PMRT (n = 26). Grade 2 skin...

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

16/05/2021
/ Publications
/
Dosimetry
Reirradiation
Toxicity

A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...